Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boulder/denver blog main
boulder/denver top stories
clinical trials
7
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
7
×
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
sanofi
7
×
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
7
×
wisconsin top stories
boston top stories
fda
biotech
abbvie
cancer
gene therapy
gilead sciences
johnson & johnson
novartis
startups
cancer immunotherapy
crispr
deals
What
roundup
bio
ahead
american
annual
cancer
congress
days
month
pharma
society
abbvie’s
acquisitions
alzheimer’s
ambien
announced
asco
ash
attendees
attention
biofourmis
biopharma
biotech
black
blood
borne
bucks
camp’s
cancers
cash
celebrate
ceo
chance
chicago
city
clinical
collabs
combinations
community’s
companies
Language
unset
Current search:
national
×
sanofi
×
" wisconsin blog main "
×
" clinical trials "
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com
5 years ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More